 Genetic Technologies NASDAQ: GENE shares are trading higher after the company provided an update on its COVID-19 severity risk test, saying predictive capabilities improved 100 over age and sex alone. Genetic Technologies is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage womens health. 